G

Guangdong Hec Technology Holding Co Ltd
SSE:600673

Watchlist Manager
Guangdong Hec Technology Holding Co Ltd
SSE:600673
Watchlist
Price: 9.25 CNY 1.09% Market Closed
Market Cap: 27.4B CNY
Have any thoughts about
Guangdong Hec Technology Holding Co Ltd?
Write Note

Guangdong Hec Technology Holding Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangdong Hec Technology Holding Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
G
Guangdong Hec Technology Holding Co Ltd
SSE:600673
Income from Continuing Operations
ÂĄ214.9m
CAGR 3-Years
-22%
CAGR 5-Years
-34%
CAGR 10-Years
1%
C
China Hongqiao Group Ltd
HKEX:1378
Income from Continuing Operations
ÂĄ19.5B
CAGR 3-Years
7%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Shandong Nanshan Aluminium Co Ltd
SSE:600219
Income from Continuing Operations
ÂĄ5.8B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
20%
Aluminum Corporation of China Ltd
SSE:601600
Income from Continuing Operations
ÂĄ18.4B
CAGR 3-Years
28%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Yunnan Aluminium Co Ltd
SZSE:000807
Income from Continuing Operations
ÂĄ6.2B
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tianshan Aluminum Group Co Ltd
SZSE:002532
Income from Continuing Operations
ÂĄ3.7B
CAGR 3-Years
-2%
CAGR 5-Years
38%
CAGR 10-Years
43%
No Stocks Found

Guangdong Hec Technology Holding Co Ltd
Glance View

Market Cap
27.9B CNY
Industry
Metals & Mining

Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.

Intrinsic Value
16.24 CNY
Undervaluation 43%
Intrinsic Value
Price
G

See Also

What is Guangdong Hec Technology Holding Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
214.9m CNY

Based on the financial report for Sep 30, 2024, Guangdong Hec Technology Holding Co Ltd's Income from Continuing Operations amounts to 214.9m CNY.

What is Guangdong Hec Technology Holding Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
1%

Over the last year, the Income from Continuing Operations growth was -27%. The average annual Income from Continuing Operations growth rates for Guangdong Hec Technology Holding Co Ltd have been -22% over the past three years , -34% over the past five years , and 1% over the past ten years .

Back to Top